--- title: "12 Health Care Stocks Moving In Monday's Pre-Market Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/288272834.md" description: "In Monday's pre-market session, several healthcare stocks showed significant movement. Genenta Science surged 134.9% to $2.42, while AIM ImmunoTech rose 23.34% to $0.5. Other gainers included Hyperliquid Strategies, Geovax Labs, Conexeu Sciences, and GT Biopharma. Conversely, Oculis Holding dropped 30.7% to $15.74, with Aditxt, PRF Technologies, Clearmind Medicine, BiomX, and Neogen also declining." datetime: "2026-06-01T12:06:23.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/288272834.md) - [en](https://longbridge.com/en/news/288272834.md) - [zh-HK](https://longbridge.com/zh-HK/news/288272834.md) --- # 12 Health Care Stocks Moving In Monday's Pre-Market Session ### Gainers - **Genenta Science** (NASDAQ:GNTA) shares moved upwards by 134.9% to $2.42 during Monday's pre-market session. The market value of their outstanding shares is at $24.1 million. - **AIM ImmunoTech** (AMEX:AIM) stock moved upwards by 23.34% to $0.5. The company's market cap stands at $5.9 million. - **Hyperliquid Strategies** (NASDAQ:PURR) shares moved upwards by 19.81% to $11.97. The market value of their outstanding shares is at $1.4 billion. - **Geovax Labs** (NASDAQ:GOVX) shares moved upwards by 13.61% to $2.34. The company's market cap stands at $10.7 million. - **Conexeu Sciences** (NASDAQ:CNXU) stock increased by 13.0% to $13.25. The company's market cap stands at $245.2 million. - **GT Biopharma** (NASDAQ:GTBP) stock increased by 12.86% to $0.54. The company's market cap stands at $17.2 million. ### Losers - **Oculis Holding** (NASDAQ:OCS) shares declined by 30.7% to $15.74 during Monday's pre-market session. The market value of their outstanding shares is at $1.3 billion. - **Aditxt** (NASDAQ:ADTX) stock decreased by 24.75% to $0.09. - **PRF Technologies** (NASDAQ:PRFX) stock decreased by 24.01% to $2.28. The market value of their outstanding shares is at $2.6 million. - **Clearmind Medicine** (NASDAQ:CMND) stock decreased by 22.35% to $2.78. The company's market cap stands at $3.6 million. - **BiomX** (AMEX:PHGE) stock declined by 12.7% to $1.1. The company's market cap stands at $12.7 million. - **Neogen** (NASDAQ:NEOG) shares fell 12.49% to $7.85. The market value of their outstanding shares is at $1.9 billion. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [GOVX.US](https://longbridge.com/en/quote/GOVX.US.md) - [AIM.US](https://longbridge.com/en/quote/AIM.US.md) - [ADTX.US](https://longbridge.com/en/quote/ADTX.US.md) - [PHGE.US](https://longbridge.com/en/quote/PHGE.US.md) - [NEOG.US](https://longbridge.com/en/quote/NEOG.US.md) - [GOVXW.US](https://longbridge.com/en/quote/GOVXW.US.md) - [GTBP.US](https://longbridge.com/en/quote/GTBP.US.md) - [OCS.US](https://longbridge.com/en/quote/OCS.US.md) - [GNTA.US](https://longbridge.com/en/quote/GNTA.US.md) - [CMND.US](https://longbridge.com/en/quote/CMND.US.md) - [PURR.US](https://longbridge.com/en/quote/PURR.US.md) - [CNXU.US](https://longbridge.com/en/quote/CNXU.US.md) - [PRFX.US](https://longbridge.com/en/quote/PRFX.US.md) - [AIMID.US](https://longbridge.com/en/quote/AIMID.US.md) - [AIMI.US](https://longbridge.com/en/quote/AIMI.US.md) - [OCSAW.US](https://longbridge.com/en/quote/OCSAW.US.md) ## Related News & Research - [AIM ImmunoTech Prices $1.3 Million Registered Direct Offering; Adds $5.3 Million Warrant Upside](https://longbridge.com/en/news/289510301.md) - [Aditxt Signed Definitive Agreement Valuing Ignite Proteomics at Approximately $150 Million | ADTX Stock News](https://longbridge.com/en/news/289184727.md) - [Clearmind completes Part A dosing in Phase I/II CMND-100 trial for alcohol use disorder](https://longbridge.com/en/news/289911348.md) - [Aditxt Subsidiary Ignite to Merge With Copley SPAC; Pubco to Issue $150 Million in Stock](https://longbridge.com/en/news/289380567.md) - [EXCLUSIVE: GT Biopharma Sees Faster Discovery, Productivity Following AI Technology Rollout](https://longbridge.com/en/news/288268171.md)